Twitter | Search | |
Search Refresh
Mohamad Mohty Dec 9
Amazing era for hematology
Reply Retweet Like
Jacob Plieth Dec 4
Post chillaxing time
Reply Retweet Like
SPAQI Aug 5
The results of the PAUSE study on periop management of patients on DOACs (abstract at ) has officially been published today in ! "Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant"
Reply Retweet Like
Sagar Lonial MD Dec 4
Interesting ride? By bye San Diego ⁦⁩ ⁦
Reply Retweet Like
Luciano J Costa Jan 2
Replying to @MediHumdani @NEJM
Someone needs to see that CAR-T emperor has no clothes. Not , not (half the abstracts with more authors than patients). I am sure there is value, but currently a big bubble.
Reply Retweet Like
Russell Ryan Dec 10
I’m excited and honored to receive a 2019 Junior Faculty Scholar Award from the American Society of Hematology. Feeling inspired by all the great research I saw a week ago at .
Reply Retweet Like
Jacob Plieth Dec 6
Winners and losers of , via & . It could have been a lot worse
Reply Retweet Like
Memorial Sloan Kettering Cancer Center Dec 13
For the first time, researchers have found an association between the makeup of the microorganisms in the body before a bone marrow transplant and a patient’s survival afterward.
Reply Retweet Like
Vincent Rajkumar Dec 27
My frank thoughts on the MAIA trial in myeloma published in Standard of care? No, not so fast.
Reply Retweet Like
Hetty Carraway Dec 4
Dr Mikkael Sekeres & Dr Mark Crowther moderated an amazing line up of for fantastic late breaking abstract session at ! Drs. Khorana, Falcon, Serrano, Shanafelt, Douketis & Blombery. ⁦⁩ ⁦⁩ ⁦⁩ ⁦
Reply Retweet Like
Brad Loncar Jan 27
At everyone was focused on the complexities of the preconditioning regimen and the effects of that. Here you are seeing the other side of the story - the seriousness of the disease and how life changing a gene Tx approach can be.
Reply Retweet Like
Rebecca Robbins Dec 6
The latest ep of our biotech podcast is out! On the docket this week: 🔹 tries to make biotech IPO history 🔹 and the quest to cure sickle cell disease 🔹 on 's drug approval dreaded by patients
Reply Retweet Like
Ben Fidler Dec 4
BCMA Day: At , Cell Therapies For Myeloma Take Center Stage
Reply Retweet Like
Cleveland Clinic MD Dec 4
. discusses the results of a new study that showed oral anticoagulants are effective at preventing blood clots in high-risk cancer patients.
Reply Retweet Like
Cancer Support Community Dec 4
We are at presenting new research on treatment decision making for people living with chronic myeloid leukemia.
Reply Retweet Like
chadi nabhan MD, MBA Dec 12
Enjoyed being on this podcast with @VPplenarysesh during ; we discussed challenges of “RWE”, policy/regulatory topics, and how career transitions are not always planned, but need to be embraced. Thanks for the opportunity to connect with your listeners.
Reply Retweet Like
Husam Qanash Dec 5
It was a very great opportunity and experience to present my Ph.D. project at . Thank you to &
Reply Retweet Like
Bertrand Delsuc Dec 5
Reply Retweet Like
Rob Dean, MD Dec 4
Just when you think that flying ✈️ can’t get more silly, makes every attendee from remove the two-pound Education Book 📖 from their checked bag 🧳 and carry it on, because their security scanners can’t handle the density (of the knowledge! 🧠).
Reply Retweet Like
Naveen Pemmaraju, MD Dec 21
Selecting Frontline Therapy for CLL in 2018 | by Dr Nitin Jain ⁦⁩ ⁦
Reply Retweet Like